| mRNA-based therapeutics: powerful and versatile tools to combat diseases S Qin, X Tang, Y Chen, K Chen, N Fan, W Xiao, Q Zheng, G Li, Y Teng, ... Signal transduction and targeted therapy 7 (1), 166, 2022 | 269 | 2022 |
| Immunotherapy for treating methamphetamine, heroin and cocaine use disorders T Xiaoshan, Y Junjie, W Wenqing, Z Yunong, L Jiaping, L Shanshan, ... Drug Discovery Today 25 (3), 610-619, 2020 | 31 | 2020 |
| Structure-based discovery of a specific TLR1–TLR2 small molecule agonist from the ZINC drug library database Z Chen, X Cen, J Yang, X Tang, K Cui, K Cheng Chemical Communications 54 (81), 11411-11414, 2018 | 22 | 2018 |
| Autophagy induced by STING, an unnoticed and primordial function of cGAS J Yang, X Tang, KS Nandakumar, K Cheng Cellular & Molecular Immunology 16 (8), 683-684, 2019 | 20 | 2019 |
| Synthesis, structure-activity relationships and preliminary mechanism study of N-benzylideneaniline derivatives as potential TLR2 inhibitors S Cai, G Zhu, X Cen, J Bi, J Zhang, X Tang, K Chen, K Cheng Bioorganic & Medicinal Chemistry 26 (8), 2041-2050, 2018 | 18 | 2018 |
| Engineered bacteriophages containing anti-CRISPR suppress infection of antibiotic-resistant P. aeruginosa S Qin, Y Liu, Y Chen, J Hu, W Xiao, X Tang, G Li, P Lin, Q Pu, Q Wu, ... Microbiology Spectrum 10 (5), e01602-22, 2022 | 14 | 2022 |
| A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants S Qin, H Huang, W Xiao, K Chen, X He, X Tang, Z Huang, Y Zhang, ... Acta Pharmaceutica Sinica B 13 (10), 4291-4304, 2023 | 4 | 2023 |
| A novel deep generative model for mRNA vaccine development: Designing 5′ UTRs with N1-methyl-pseudouridine modification X Tang, M Huo, Y Chen, H Huang, S Qin, J Luo, Z Qin, X Jiang, Y Liu, ... Acta Pharmaceutica Sinica B 14 (4), 1814-1826, 2024 | | 2024 |
